Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unr...
Main Authors: | Lieqiang Xu, Juanjuan Cheng, Jieyi Lu, Guoshu Lin, Qiuxia Yu, Yucui Li, Jiannan Chen, Jianhui Xie, Ziren Su, Qi Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.964593/full |
Similar Items
-
Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System
by: Li M, et al.
Published: (2022-12-01) -
Quality Evaluation of Phellodendri Chinensis Cortex by Fingerprint–Chemical Pattern Recognition
by: Xuexiao Cao, et al.
Published: (2018-09-01) -
Rapid and simultaneous determination of moisture and berberine content in Coptidis Rhizoma and Phellodendri Chinensis Cortex by near-infrared spectroscopy and chemometrics
by: Siyu Zhang, et al.
Published: (2020-03-01) -
PREPARATIVE SEPARATION OF ISOQUINOLINE ALKALOIDS FROM PHELLODENDRI CORTEX BY PH-ZONE-REFINING COUNTER-CURRENT CHROMATOGRAPHY
by: Daijie Wang, et al. -
Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
by: Lieqiang Xu, et al.
Published: (2021-04-01)